NextCure Files Proxy for 2025 Shareholder Meeting

Ticker: NXTC · Form: DEFA14A · Filed: May 19, 2025 · CIK: 1661059

Nextcure, Inc. DEFA14A Filing Summary
FieldDetail
CompanyNextcure, Inc. (NXTC)
Form TypeDEFA14A
Filed DateMay 19, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, shareholder-notice

TL;DR

NextCure's proxy materials are out for the June 20th shareholder meeting. Vote wisely.

AI Summary

NextCure, Inc. is filing supplemental material for its 2025 Annual Meeting of Stockholders, scheduled for Friday, June 20, 2025. This filing is a definitive proxy statement, indicating it contains the final information for shareholders regarding the meeting. The company is based in Beltsville, Maryland.

Why It Matters

This filing provides shareholders with crucial information to make informed decisions and vote at the upcoming annual meeting, impacting the company's governance and future direction.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual shareholder meeting, not indicating any immediate financial or operational risks.

Key Players & Entities

  • NextCure, Inc. (company) — Registrant and filer of the proxy statement
  • June 20, 2025 (date) — Date of the 2025 Annual Meeting of Stockholders
  • Beltsville, Maryland (location) — Location of NextCure, Inc.'s business and mailing address

FAQ

What is the purpose of this DEFA14A filing?

This filing is supplemental material to the proxy statement for NextCure, Inc.'s 2025 Annual Meeting of Stockholders, providing definitive information for shareholders.

When is the 2025 Annual Meeting of Stockholders for NextCure, Inc.?

The 2025 Annual Meeting of Stockholders for NextCure, Inc. is scheduled to be held on Friday, June 20, 2025.

Where is NextCure, Inc. located?

NextCure, Inc.'s business and mailing address is 9000 Virginia Manor Road, Suite 200, Beltsville, Maryland 20705.

What is the filing type and date?

The filing type is DEFA14A (Definitive Proxy Statement), filed as of date May 19, 2025.

What is the SIC code for NextCure, Inc.?

The Standard Industrial Classification (SIC) code for NextCure, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 19, 2025 regarding NextCure, Inc. (NXTC).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.